Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments

Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments

Gliomas are one of the most lethal types of cancers accounting for ∼80% of all central nervous system (CNS) primary malignancies. Among gliomas, glioblastomas (GBM) are the most aggressive, characterized by a median patient survival of fewer than 15  months. Recent molecular characterization studies...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Mahmoud S. Alghamri, Brandon L. McClellan, Carson S. Hartlage, Santiago Haase, Syed Mohd Faisal, Rohit Thalla, Ali Dabaja, Kaushik Banerjee, Stephen V. Carney, Anzar A. Mujeeb, Michael R. Olin, James J. Moon, Anna Schwendeman, Pedro R. Lowenstein, Maria G. Castro
Materialtyp: Artikel
Språk:English
Publicerad: Frontiers Media S.A. 2021-05-01
Serie:Frontiers in Pharmacology
Ämnen:
immunosuppression
inflammation
tumor microenvironment
glioma
immunotherapy
Länkar:https://www.frontiersin.org/articles/10.3389/fphar.2021.680021/full

Liknande verk

Liknande verk